NO20073823L - Kinolinderivater for behandlingen av latent tuberkulose - Google Patents

Kinolinderivater for behandlingen av latent tuberkulose

Info

Publication number
NO20073823L
NO20073823L NO20073823A NO20073823A NO20073823L NO 20073823 L NO20073823 L NO 20073823L NO 20073823 A NO20073823 A NO 20073823A NO 20073823 A NO20073823 A NO 20073823A NO 20073823 L NO20073823 L NO 20073823L
Authority
NO
Norway
Prior art keywords
alkyl
hydrogen
het
alkyloxy
alkylthio
Prior art date
Application number
NO20073823A
Other languages
English (en)
Other versions
NO340376B1 (no
Inventor
Koenraad Jozef Lodewij Andries
Anil Koul
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35717702&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20073823(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20073823L publication Critical patent/NO20073823L/no
Publication of NO340376B1 publication Critical patent/NO340376B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Anvendelse av en forbindelse med formel (Ia) eller (Ib) for fremstillingen av et medikament for behandlingen av latent tuberkulose, hvori forbindelsen med formel (Ia) eller (Ib) er (Ia) (Ib) et farmasøytisk akseptabelt salt, et kvaternært amin, et N-oksid, en tautomer form eller en stereokjemisk isomer form derav hvori R1 er hydrogen, halo, haloalkyl, cyano, hydroksy, Ar, Het, alkyl, alkyloksy, alkyltio, alkyloksyalkyl, alkyltioalkyl, Ar-alkyl eller di(Ar)alkyl; p er 1, 2, 3 eller 4; R2 er hydrogen, hydroksy, merkapto, alkyloksy, alkyloksyalkyloksy, alkyltio, mono eller di(alkyl)amino eller et radikal med formel ; R3 er alkyl, Ar, Ar-alkyl, Het eller Het-alkyl; q er null, 1, 2, 3 eller 4; R4 og R5 er hver uavhengig hydrogen, alkyl eller benzyl; eller R4 og R5 kan tas sammen inklusive N til hvilket de er bundet; R6 er hydrogen, halo, haloalkyl, hydroksy, Ar, alkyl, alkyloksy, alkyltio, alkyloksyalkyl, alkyltioalkyl, Ar-alkyl eller di(Ar)alkyl; eller to vicinale R6-radikaler kan tas sammen for å danne et bivalent radikal -CH=CH-CH=CH-; r er 1, 2, 3, 4 eller 5; R7 er hydrogen, alkyl, Ar eller Het; R8 er hydrogen eller alkyl; R9 er okso; eller R8 og R9 danner sammen radikalet =N-CH=CH- . ?? ?? ?? ?? 1
NO20073823A 2004-12-24 2007-07-23 Kinolinderivater for behandlingen av latent tuberkulose NO340376B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04078529 2004-12-24
EP05105008 2005-06-08
PCT/EP2005/056594 WO2006067048A1 (en) 2004-12-24 2005-12-08 Quinoline derivatives for the treatment of latent tuberculosis

Publications (2)

Publication Number Publication Date
NO20073823L true NO20073823L (no) 2007-07-23
NO340376B1 NO340376B1 (no) 2017-04-10

Family

ID=35717702

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073823A NO340376B1 (no) 2004-12-24 2007-07-23 Kinolinderivater for behandlingen av latent tuberkulose

Country Status (30)

Country Link
US (1) US20060142279A1 (no)
EP (1) EP1830850B1 (no)
CN (1) CN103142595B (no)
AP (1) AP2327A (no)
AR (1) AR051790A1 (no)
AT (1) ATE501721T1 (no)
AU (1) AU2005242138B2 (no)
BR (1) BRPI0506400B8 (no)
CA (1) CA2529265C (no)
CR (1) CR9267A (no)
CY (1) CY1112247T1 (no)
DE (1) DE602005026984D1 (no)
DK (1) DK1830850T3 (no)
EE (1) EE05394B1 (no)
HR (1) HRP20110392T1 (no)
IL (1) IL184123A (no)
LV (1) LV13469B (no)
ME (1) ME01207B (no)
MY (1) MY145845A (no)
NI (1) NI200700146A (no)
NO (1) NO340376B1 (no)
NZ (1) NZ555460A (no)
PA (1) PA8654801A1 (no)
PL (1) PL1830850T3 (no)
PT (1) PT1830850E (no)
RS (1) RS51730B (no)
SI (1) SI1830850T1 (no)
TR (1) TR200504892A1 (no)
TW (1) TWI404535B (no)
WO (1) WO2006067048A1 (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO342701B1 (no) * 2005-06-28 2018-07-09 Janssen Pharmaceutica Nv Kinolinderivater som antibakterielle midler

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1527050T1 (sl) * 2002-07-25 2010-08-31 Janssen Pharmaceutica Nv Kinolinski derivati in njihova uporaba kot mikobakterijski inhibitorji
JO3270B1 (ar) * 2005-06-28 2018-09-16 Janssen Pharmaceutica Nv مشتقات كوينولين بصفة عوامل مضادة للبكتيريا
KR101329587B1 (ko) * 2005-06-28 2013-11-15 얀센 파마슈티카 엔.브이. 항균제로서의 퀴놀린 유도체
JO2970B1 (en) * 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO3271B1 (ar) 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
JO2725B1 (en) * 2006-12-06 2013-09-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
US20110059948A1 (en) * 2008-01-14 2011-03-10 Jyoti Chattopadhyaya Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivatives as anti-mycobacterial agents
RU2404971C2 (ru) * 2008-12-02 2010-11-27 ЗАО "Фарм-Синтез" Новые производные хинолина, способ их получения, их применение для лечения микобактериальных инфекций, фармацевтическая композиция на их основе
CA2751892A1 (en) 2009-01-15 2010-07-22 Rutgers, The State University Of New Jersey Benzo [c] phenanthridines as antimicrobial agents
CA2760526A1 (en) 2009-04-30 2010-11-04 Rutgers, The State University Of New Jersey Antimicrobial agents
US8933096B2 (en) 2010-06-09 2015-01-13 Rugers, The State University of New Jersey Antimicrobial agents
WO2011163610A2 (en) * 2010-06-25 2011-12-29 Rutgers, The State University Of New Jersey Antimicrobial agents
WO2013106756A2 (en) 2012-01-13 2013-07-18 Rutgers, The State University Of New Jersey Antimicrobial agents
EP2828245A1 (en) 2012-03-21 2015-01-28 Rutgers, The State University of New Jersey Antimicrobial agents
ES2576491T3 (es) 2012-04-27 2016-07-07 Janssen Pharmaceutica, N.V. Derivados de quinolina antibacterianos
AU2013254670B2 (en) 2012-04-27 2017-03-30 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
US9458150B2 (en) 2013-11-08 2016-10-04 Rutgers, The State University Of New Jersey Antimicrobial agents
KR102631986B1 (ko) 2015-01-27 2024-01-30 얀센 파마슈티카 엔브이 분산성 조성물
WO2017147316A1 (en) 2016-02-25 2017-08-31 Taxis Pharmaceuticals, Inc. Synthetic processes and intermediates
EA201891644A1 (ru) * 2016-03-07 2019-04-30 Зе Глобал Эллайенс Фо Тб Драг Девелопмент, Инк. Антибактериальные соединения и их применение
RU2629369C1 (ru) * 2016-10-05 2017-08-29 Федеральное Государственное Унитарное Предприятие "Государственный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Химических Реактивов И Особо Чистых Химических Веществ" Четвертичные аммонийные производные 2-аминотиофен-3-карбоксилатов, обладающие противотуберкулезной активностью
CN110891566B (zh) 2017-03-30 2023-12-19 塔克西斯医药股份有限公司 合成方法和合成中间体
AU2018298855B2 (en) 2017-07-14 2024-07-18 Janssen Pharmaceutica Nv Long-acting formulations
RU2661151C1 (ru) * 2017-12-14 2018-07-12 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Селективные ингибиторы глицеральдегид-3-фосфатдегидрогеназы микобактерий
CN122320982A (zh) 2019-01-09 2026-07-03 詹森药业有限公司 治疗非结核分枝杆菌疾病的组合
JP2023533014A (ja) 2020-07-09 2023-08-01 ヤンセン ファーマシューティカ エヌ.ベー. 長時間作用型配合物
CA3182854A1 (en) 2020-07-09 2022-01-13 Rene Holm Long-acting formulations
TW202233168A (zh) 2020-11-12 2022-09-01 比利時商健生藥品公司 治療非結核分枝桿菌疾病的藥物組分之組合
WO2023232838A1 (en) 2022-05-31 2023-12-07 Janssen Pharmaceutica Nv Bedaquiline for use in the treatment of leprosy
WO2024068693A1 (en) 2022-09-28 2024-04-04 Janssen Pharmaceutica Nv Long-acting formulations
TW202423427A (zh) 2022-09-28 2024-06-16 比利時商健生藥品公司 長效配方
WO2025068448A1 (en) 2023-09-28 2025-04-03 Janssen Pharmaceutica Nv Atp synthase inhibitors for use in the treatment of non-tuberculosis mycobacteria

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
SI1527050T1 (sl) * 2002-07-25 2010-08-31 Janssen Pharmaceutica Nv Kinolinski derivati in njihova uporaba kot mikobakterijski inhibitorji

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO342701B1 (no) * 2005-06-28 2018-07-09 Janssen Pharmaceutica Nv Kinolinderivater som antibakterielle midler

Also Published As

Publication number Publication date
AR051790A1 (es) 2007-02-07
WO2006067048A1 (en) 2006-06-29
EE05394B1 (et) 2011-04-15
AU2005242138B2 (en) 2011-05-26
DK1830850T3 (da) 2011-06-14
TW200637551A (en) 2006-11-01
HK1186125A1 (en) 2014-03-07
EP1830850B1 (en) 2011-03-16
NZ555460A (en) 2008-11-28
PL1830850T3 (pl) 2011-07-29
BRPI0506400A (pt) 2006-08-29
CN103142595B (zh) 2015-05-06
IL184123A0 (en) 2008-12-29
DE602005026984D1 (de) 2011-04-28
NI200700146A (es) 2019-05-10
SI1830850T1 (sl) 2011-07-29
BRPI0506400B1 (pt) 2021-04-06
TWI404535B (zh) 2013-08-11
PA8654801A1 (es) 2006-08-03
CR9267A (es) 2008-09-09
EP1830850A1 (en) 2007-09-12
BRPI0506400B8 (pt) 2021-05-25
HRP20110392T1 (hr) 2011-06-30
LV13469B (en) 2007-01-20
NO340376B1 (no) 2017-04-10
CA2529265C (en) 2014-02-11
TR200504892A1 (tr) 2010-04-21
RS51730B (sr) 2011-10-31
BRPI0506400A8 (pt) 2017-09-12
MY145845A (en) 2012-04-30
EE200500033A (et) 2006-08-15
ATE501721T1 (de) 2011-04-15
AP2007004054A0 (en) 2007-06-30
CA2529265A1 (en) 2006-06-24
AU2005242138A1 (en) 2006-07-13
US20060142279A1 (en) 2006-06-29
CN103142595A (zh) 2013-06-12
PT1830850E (pt) 2011-05-31
CY1112247T1 (el) 2015-12-09
AP2327A (en) 2011-11-25
IL184123A (en) 2011-10-31
ME01207B (me) 2013-03-20

Similar Documents

Publication Publication Date Title
TW200637551A (en) Treatment of latent tuberculosis
NO20080955L (no) Kinolinderivater som antibakterielle midler
NO20081026L (no) Kinolinderivater som antibakterielle midler
NO20080499L (no) Kinolinderivater som antibakterielle midler
NO20081068L (no) Kinolinderivater som antibakterielle midler
NO20080501L (no) Kinolinderivater som antibakterielle midler
EA200601363A1 (ru) Замещённые хинолины и их применение в качестве микобактериальных ингибиторов
JO2695B1 (en) Treatment of latent TB
NO20080481L (no) Kinolinderivater som antibakterielle midler
TH80291A (th) การรักษาวัณโรคแฝง